Cohort A will receive an initial load dose of 8mg/kg and a maintenance dose of 6mg/kg intravenously on the first day of every three weeks for a total of 4 doses
OBU-BC-II-206
Approved small_molecule active
Quick answer
Cohort A will receive an initial load dose of 8mg/kg and a maintenance dose of 6mg/kg intravenously on the first day of every three weeks for a total of 4 doses for HER2 Positive Breast Cancer is a Approved program (small_molecule) at First Tracks Biotherapeutics with 1 ClinicalTrials.gov record(s).
Program details
- Company
- First Tracks Biotherapeutics
- Indication
- HER2 Positive Breast Cancer
- Phase
- Approved
- Modality
- small_molecule
- Status
- active